Diacylglycerol: efficacy and mechanism of action of an anti-obesity agent (Q36336730)

13 August 2017

1 reference

title

Diacylglycerol: efficacy and mechanism of action of an anti-obesity agent (English)

1 reference

13 August 2017

0 references

Iwona Rudkowska

1

1 reference

13 August 2017

Catherine E Roynette

2

1 reference

13 August 2017

Isabelle Demonty

3

1 reference

13 August 2017

Catherine A Vanstone

4

1 reference

13 August 2017

Stephanie Jew

5

1 reference

13 August 2017

Peter J H Jones

6

1 reference

13 August 2017

language of work or name

1 reference

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

13

1 reference

13 August 2017

11

1 reference

13 August 2017

1864-1876

1 reference

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

13 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Lipid-based fat substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Nutritional characteristics of DAG oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dietary diacylglycerol prevents high-fat diet-induced lipid accumulation in rat liver and abdominal adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Studies on the role of dietary diacylglycerols in human nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Advances in the application of imaging methods in applied and clinical physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Postprandial triglyceride response in visceral obesity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Digestion and assimilation features of dietary DAG in the rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Chronic study of diacylglycerol oil in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Effect of phytosterols in dietary diacylglycerol on atherosclerosis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dynamics of postprandial remnant-like lipoprotein particles in serum after loading of diacylglycerols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Solubilization of phytosterols in diacylglycerol versus triacylglycerol improves the serum cholesterol-lowering effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Physiological actions of diacylglycerol outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Fat intake and energy-balance effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

DGAT and triglyceride synthesis: a new target for obesity treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Fat-soluble vitamin status is not affected by diacylglycerol consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Genotoxicity studies on dietary diacylglycerol (DAG) oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Safety aspects regarding the consumption of high-dose dietary diacylglycerol oil in men and women in a double-blind controlled trial in comparison with consumption of a triacylglycerol control oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Reciprocal responses to dietary diacylglycerol of hepatic enzymes of fatty acid synthesis and oxidation in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dietary alpha-linolenic acid-rich diacylglycerols reduce body weight gain accompanying the stimulation of intestinal beta-oxidation and related gene expressions in C57BL/KsJ-db/db mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Comparisons of glucose and lipid metabolism in rats fed diacylglycerol and triacylglycerol oils.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Diacylglycerols affect substrate oxidation and appetite in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dietary diacylglycerol-rich oil stimulation of glucose intolerance in genetically obese rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Long-term ingestion of dietary diacylglycerol lowers serum triacylglycerol in type II diabetic patients with hypertriglyceridemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Significant effects of diacylglycerol on body fat and lipid metabolism in patients on hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dietary diacylglycerol-dependent reduction in serum triacylglycerol concentration in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Dietary diacylglycerol suppresses high fat diet-induced hepatic fat accumulation and microsomal triacylglycerol transfer protein activity in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Improvement in blood lipid levels by dietary sn-1,3-diacylglycerol in young women with variants of lipid transporters 54T-FABP2 and -493g-MTP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Effects of diacylglycerol administration on serum triacylglycerol in a patient homozygous for complete lipoprotein lipase deletion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

Energy value and digestibility of dietary oil containing mainly 1,3-diacylglycerol are similar to those of triacylglycerol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.229

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.229

1 reference

13 August 2017

1 reference